GENE ONLINE|News &
Opinion
Blog

2025-04-28|

Single HPV Vaccine Dose Shows Similar Protection to Two Doses in Recent Study

by Mark Chiang
Share To

NEWSFLASH

A recent study indicates that a single dose of the HPV vaccine demonstrates comparable effectiveness to the standard two-dose regimen in preventing HPV infection. The study suggests a potential reduction in the number of doses required for effective immunization against the virus. Researchers observed that individuals who received a single dose of the HPV vaccine exhibited similar levels of protection against HPV infection as those who received the two-dose series. The findings offer the possibility of simplifying vaccination schedules and potentially improving vaccine access and coverage rates.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top